rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Katherine A. Eade

Director

Company insider

Files Form 4 as: Director, Harvard Bioscience; Director, Vaxxinity.

In numbers

Trades disclosed
22
Buys
1
Sells
0
Bought
$99K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
30 Oct 2017
Last trade
9 Jun 2026
Last filed
12 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
HBIO Harvard BioscienceDirector · Life-science tools · last 9 Jun 20261 buy · 0 sells
VaxxinityDirector · last 20 Jun 20230 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 12 Jun 2026HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—16,556 at $0.00filing
9 Jun 2026filed 12 Jun 2026HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—16,556 at $0.00filing
16 Jul 2025filed 18 Jul 2025HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—110,000 at $0.00filing
21 May 2024filed 23 May 2024HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—45,872 at $0.00filing
20 Jun 2023filed 26 Jun 2023Vaxxinityoption or derivativeSEC FORM 4 Code A—132,352 at $0.00filing
22 May 2023filed 23 May 2023HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—25,554 at $0.00filing
24 May 2022filed 26 May 2022HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—38,259 at $0.00filing
1 Jan 2022filed 3 Jan 2022HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—2,525 at $0.00filing
28 Dec 2021filed 29 Dec 2021HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—1,401 at $0.00filing
25 May 2021filed 27 May 2021HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—14,400 at $0.00filing
4 Jan 2021filed 6 Jan 2021HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—14,200 at $0.00filing
18 Jun 2020filed 19 Jun 2020HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—28,100 at $0.00filing
2 Jan 2020filed 3 Jan 2020HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—19,300 at $0.00filing
9 Aug 2019filed 12 Aug 2019HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Bought$99K39,915 at $2.48filing
1 Aug 2019filed 1 Aug 2019HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—1,100 at $0.00filing
23 May 2019filed 24 May 2019HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—35,100 at $0.00filing
2 Jan 2019filed 3 Jan 2019HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—12,700 at $0.00filing
1 Jun 2018filed 5 Jun 2018HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—1,200 at $0.00filing
24 May 2018filed 29 May 2018HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—18,100 at $0.00filing
2 Jan 2018filed 4 Jan 2018HBIO Harvard BioscienceLife-science toolsSEC FORM 4 Code A—11,100 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Stephen J. DenelskyDirector · Director at Harvard Bioscience, filing Form 4 there in the last year
William SniderDirector · Director at Harvard Bioscience, filing Form 4 there in the last year
Robert E. GagnonDirector · Director at Harvard Bioscience, filing Form 4 there in the last year
Seth Benjamin BensonDirector · Director at Harvard Bioscience, filing Form 4 there in the last year
Mark T. FrostChief Financial Officer · Chief Financial Officer at Harvard Bioscience, filing Form 4 there in the last year